MobiCare
DeviceIt is a 9.2g wearable electrocardiogram device, mobiCARE, in the form of a patch, and the model name is MC200M.
NCT Number: NCT05725187
The purpose of this study is to predict the occurrence of paroxysmal atrial fibrillation by finding high-risk group from normal sinus rhythm ECG through artificial intelligence-based prediction algorithm.
Interested in participating?
Request Info20 year and older
All sexes
Observational
Chonnam National University Hospital, Gwangju, South Korea
This study is a multi-center, prospective observational validation study. Patients aged 18 or above who are hospitalized at our hospital or who visited the outpatient clinic with arrhythmia symptoms (such as palpitation) after the clinical research approval will be enrolled. The normal sinus rhythm electrocardiogram (ECG) at the time of participation in the study is recorded and put into the artificial intelligence prediction algorithm. The result of risk stratification is blinded and will not be informed to both the research director and subjects. After applying wearable devices to the subject, the ECG recorded for the first week is analyzed to confirm the occurrence of paroxysmal atrial fibrillation (the gold standard for diagnosis of atrial fibrillation). When the wearable devices are removed, the 12 lead electrocardiogram will be taken again, and if it shows normal sinus rhythm electrocardiogram, then it will be put into the artificial intelligence prediction algorithm to calculate the result as well.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
It is a 9.2g wearable electrocardiogram device, mobiCARE, in the form of a patch, and the model name is MC200M.
Time frame: 1 week
The AI prediction algorithm classifies patients into high-risk and low-risk categories for predicting paroxysmal atrial fibrillation within a week, based on ECG recordings of those with normal sinus rhythm. The accuracy of the prediction will be assessed through the use of a wearable device that records occurrence of paroxysmal atrial fibrillation over the course of a week.
Time frame: 1 week
The artificial intelligence prediction algorithm categorizes patients into high-risk and low-risk groups when predicting paroxysmal atrial fibrillation within one week based on normal sinus rhythm ECG data. The AI prediction algorithm's performance is assessed based on the data obtained from the primary outcome, which involves confirming whether atrial fibrillation recorded through a week-long use of a wearable device. We will gauge the algorithm's effectiveness by evaluating its predictive abilities, encompassing sensitivity, specificity, positive predictive rate, negative predictive rate, and the F1 score.
Time frame: 10 minute
The predictive capabilities of the artificial intelligence prediction algorithm in risk stratification will be compared to the risk stratification proficiency of the experts. Each expert will be required to answer a questionnaire consisting of 30 ECGs to classify them as high risk or low risk. The questionnaire is composed of three components:
Q1. Atrial fibrillation/flutter risk prediction based on normal sinus rhythm 12-lead ECG and participant's clinical data (Age, gender, comorbidities, laboratory result, EHRA Symptom Score, etc.). The laboratory result could include BUN/Cr, eGFR, liver function test, lipid profile test.
Q2. Further plan required for identification of atrial fibrillation/flutter. Q3. Decisive evidence of atrial fibrillation/flutter risk prediction. The evidence could include normal sinus rhythm 12-lead ECG or participant's clinical data.
Ewha Womans University Mokdong Hospital
Other
Prospective Validation Study of Artificial Intelligence-based Prediction Algorithm for the Prediction of Paroxysmal Atrial Fibrillation
Acronym: PROVISION-AF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06557876
Arrhythmias, Cardiac, Atrial Fibrillation
Paris, France
View Trial DetailsNCT06172699
Ablation, Arrhythmias, Cardiac
San Diego, California, United States
View Trial DetailsNCT07018596
Arrhythmias, Cardiac, Atrial Fibrillation
Prague, Roentgenova, Czechia
View Trial DetailsNCT06696170
Arrhythmias, Cardiac, Atrial Fibrillation
Hasselt, Belgium
View Trial Details